Institute News

USC ATRI holds second annual Partnership Meeting

The USC Alzheimer’s Therapeutic Research Institute (USC ATRI) held its second annual Partnership Meeting in San Diego recently. The meeting, which was attended by 125 clinical trial protocol investigators and other trial staff who work closely with USC ATRI, brought together top researchers from around the country to collaborate and discuss methods for finding effective

... Read More

USC Vice President of Research Randolph Hall, left, joins Paul Aisen, director of the USC Alzheimer’s Therapeutic Research Institute, during the second annual partnership meeting, held Jan. 26-27 in San Diego.

Latest News

USC Vice President of Research Randolph Hall, left, joins Paul Aisen, director of the USC Alzheimer’s Therapeutic Research Institute, during the second annual partnership meeting, held Jan. 26-27 in San Diego.

USC ATRI holds second annual Partnership Meeting

The USC Alzheimer’s Therapeutic Research Institute (USC ATRI) held its second annual Partnership Meeting in San Diego recently. The meeting, which was attended by 125 clinical trial protocol investigators and other trial staff who work closely with USC ATRI, brought together top researchers from around the country to collaborate and discuss methods for finding effective

Read More

Paul Aisen, MD, the founding director of the USC Alzheimer’s Therapeutic Research Institute,

Neurologist Paul Aisen works to stop Alzheimer’s before it starts

The researcher explains five things to know about the only disease among the top 10 in America that cannot be prevented, cured or slowed Scientists at the Alzheimer’s Therapeutic Research Institute (ATRI) of the Keck School of Medicine of USC have enrolled more than 1,000 people in their international clinical trials and are still seeking more participants.

Read More

Keck faculty among the world’s most influential researchers

Sir Isaac Newton once referred to the process of discovery as “standing on the shoulders of giants,” meaning that revolutionary science and innovation is built on the work of previous researchers. Some researchers are more impactful than others. One measure of this is the number of times a particular researcher’s work is cited, thus serving

Read More

In a person with Alzheimer's, harmful amyloid beta clusters (red) build up among neurons (green) in a memory-related area of the brain. (Photo/Strittmatter Laboratory, Yale University)

New Alzheimer’s study aims to delay or prevent symptoms

The international trial co-managed by USC will test a drug in people who show no symptoms of the disease USC researchers announced Tuesday they will test a promising drug aimed at preventing or delaying the symptoms of Alzheimer’s disease. The international study, jointly managed by the USC Alzheimer’s Therapeutic Research Institute (ATRI) and Janssen Research & Development, will

Read More

Paul Aisen speaks during a USC Alzheimer's Therapeutic Research Institute Partnership Meeting in January to discuss ongoing research and treatments for the fatal neurodegenerative disease.

USC Alzheimer’s Therapeutic Research Institute hosts leading neuroscientists for two-day meeting

Top researchers from across the U.S. gathered in San Diego recently to commemorate a renewed commitment to understand and fight the leading fatal neurodegenerative disease affecting the aging population. The USC Alzheimer’s Therapeutic Research Institute (ATRI) Partnership Meeting was held in January and brought together USC leaders, neuroscientists and visiting researchers to discuss the new

Read More

Paul Aisen, MD, the founding director of the USC Alzheimer’s Therapeutic Research Institute,

Advancing Alzheimer’s treatment options through collaboration

Paul Aisen, MD, the founding director of the USC Alzheimer’s Therapeutic Research Institute, is the newest member of the Keck School of Medicine of USC whose focus is Alzheimer’s disease research. He recently spoke with us and answered a few questions about joining the Keck School and the progress of Alzheimer’s disease research over the

Read More